Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Clinical trial NCT00799110 · TERMINATED

Trial details

NCT number: NCT00799110
Sponsor: Beth Israel Deaconess Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer

Start date: 2008-05-01
Primary completion: 2025-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.